Michael A. Weber MD, FACP, FACC, FAHA

Michael A. Weber, MD is a Professor of Medicine at Downstate College of Medicine of the State University of New York. He received his medical degree from Sydney University in Australia. His career has focused largely on hypertension and preventive cardiology. He has been a leading part of several clinical trials that have helped define strategies for optimizing cardiovascular protection for patients with hypertension. He has also been very much involved with new drug development going back to the beta-blockers and through to the contemporary angiotensin receptor blockers. He has also been active in recent trials of device therapy for hypertension. He was also one of the pioneers in developing ambulatory blood pressure monitoring, a technique now recommended for clinical practice by the major clinical hypertension guideline committees.

He is an author of over 500 articles in peer-reviewed literature and has authored or edited 16 books. He was a founder of the American Society of Hypertension (ASH) and the ASH Hypertension Clinical Specialists Accreditation Program and has served as President of both those organizations. Dr. Weber maintains a strong interest in global hypertension issues and is a member of the Executive Committee of the International Society of Hypertension. He was Chair of the Writing Committee of the 2014 ASH/ISH Hypertension Clinical Practice Guidelines.

He is currently Editor in Chief of the Journal of Clinical Hypertension, the official journal of the World Hypertension League. He is a Fellow of The American College of Physicians, The American College of Cardiology, and The American Heart Association. He has served on the Cardiovascular and Renal Drugs Advisory Board of the Food and Drug Administration and continues as a consultant to that Agency. He has also served as Chairman of the Formulary Committee of a major pharmacy benefits provider serving many of the leading health plans in the United States.